Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease - Concepedia

Concepedia

Publication | Open Access

Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease

DOI Full Paper Access

148

Citations

17

References

2011

Year

Mamoru Watanabe, Toshifumi Hibi∥, Kathleen G. Lomax, Susan K. Paulson, Jingdong Chao, Mohammad Shamsul Alam, Anne Camez

Journal of Crohn s and Colitis

Abstract

Adalimumab is effective and well-tolerated for inducing and maintaining clinical remission in Japanese patients with moderate to severe Crohn's disease.

References

	Year	Citations

Page 1